AETHLON MEDICAL INC Quarterly Debt-to-equity in % from Q4 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Aethlon Medical Inc quarterly Debt-to-equity history and growth rate from Q4 2014 to Q3 2024.
  • Aethlon Medical Inc Debt-to-equity for the quarter ending September 30, 2024 was 38.6 %, a 93.8% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 38.6 +18.7 +93.8% Sep 30, 2024
Q2 2024 32.5 +14.5 +80.3% Jun 30, 2024
Q1 2024 28.5 +11.7 +69.9% Mar 31, 2024
Q4 2023 22.7 +6.4 +39.2% Dec 31, 2023
Q3 2023 19.9 +7.23 +57.1% Sep 30, 2023
Q2 2023 18 Jun 30, 2023
Q1 2023 16.8 Mar 31, 2023
Q4 2022 16.3 Dec 31, 2022
Q3 2022 12.7 Sep 30, 2022
Q1 2021 10.7 -24.6 -69.7% Mar 31, 2021
Q4 2020 10.2 -66.7 -86.8% Dec 31, 2020
Q3 2020 11.1 -85.6 -88.5% Sep 30, 2020
Q2 2020 15.6 -46.1 -74.7% Jun 30, 2020
Q1 2020 35.3 -5.93 -14.4% Mar 31, 2020
Q4 2019 76.8 +46.4 +153% Dec 31, 2019
Q3 2019 96.7 +71.6 +285% Sep 30, 2019
Q2 2019 61.7 +31.2 +102% Jun 30, 2019
Q1 2019 41.2 -8.93 -17.8% Mar 31, 2019
Q4 2018 30.4 -75 -71.2% Dec 31, 2018
Q3 2018 25.1 +81.1K Sep 30, 2018
Q2 2018 30.6 +2.48K Jun 30, 2018
Q1 2018 50.2 -316 -86.3% Mar 31, 2018
Q4 2017 105 -94.6 -47.3% Dec 31, 2017
Q3 2017 -81K -81.1K -92808% Sep 30, 2017
Q2 2017 -2.45K -2.5K -5635% Jun 30, 2017
Q1 2017 366 +339 +1237% Mar 31, 2017
Q4 2016 200 +173 +639% Dec 31, 2016
Q3 2016 87.4 +47.5 +119% Sep 30, 2016
Q2 2016 44.3 -181 -80.4% Jun 30, 2016
Q1 2016 27.4 +248 Mar 31, 2016
Q4 2015 27.1 +158 Dec 31, 2015
Q3 2015 39.9 Sep 30, 2015
Q2 2015 225 Jun 30, 2015
Q1 2015 -221 Mar 31, 2015
Q4 2014 -131 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.